495 related articles for article (PubMed ID: 28437520)
41. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
[TBL] [Abstract][Full Text] [Related]
43. When to start and stop caffeine and why respiratory status matters.
Davis PG
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
[TBL] [Abstract][Full Text] [Related]
44. Caffeine citrate in the NICU.
Flood E
Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
[TBL] [Abstract][Full Text] [Related]
45. Caffeine versus theophylline for apnea in preterm infants.
Steer PA; Henderson-Smart DJ
Cochrane Database Syst Rev; 2000; (2):CD000273. PubMed ID: 10796190
[TBL] [Abstract][Full Text] [Related]
46. Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis.
Oliphant EA; Hanning SM; McKinlay CJD; Alsweiler JM
J Perinatol; 2024 Jun; 44(6):785-801. PubMed ID: 38553606
[TBL] [Abstract][Full Text] [Related]
47. Current options in the management of apnea of prematurity.
Bhatia J
Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
[TBL] [Abstract][Full Text] [Related]
48. Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial.
Alansari K; Toaimah FH; Khalafalla H; El Tatawy LA; Davidson BL; Ahmed W
J Pediatr; 2016 Oct; 177():204-211.e3. PubMed ID: 27189681
[TBL] [Abstract][Full Text] [Related]
49. High versus standard dose caffeine for apnoea: a systematic review.
Vliegenthart R; Miedema M; Hutten GJ; van Kaam AH; Onland W
Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F523-F529. PubMed ID: 29437799
[TBL] [Abstract][Full Text] [Related]
50. Caffeine impact on neonatal morbidities.
Aranda JV; Beharry K; Valencia GB; Natarajan G; Davis J
J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():20-3. PubMed ID: 20873976
[TBL] [Abstract][Full Text] [Related]
51. Caffeine for apnea of prematurity.
Coulter DM
N Engl J Med; 2006 Aug; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
[No Abstract] [Full Text] [Related]
52. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
[TBL] [Abstract][Full Text] [Related]
53. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
[TBL] [Abstract][Full Text] [Related]
54. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
Skouroliakou M; Bacopoulou F; Markantonis SL
J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
[TBL] [Abstract][Full Text] [Related]
55. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
He T; Liao ZC; Ding Y; Wang MJ; Li W; Gan JM; Yue SJ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161
[TBL] [Abstract][Full Text] [Related]
57. Sequelae of caffeine treatment in preterm infants with apnea.
Gunn TR; Metrakos K; Riley P; Willis D; Aranda JV
J Pediatr; 1979 Jan; 94(1):106-9. PubMed ID: 363996
[TBL] [Abstract][Full Text] [Related]
58. Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants.
Lodha A; Entz R; Synnes A; Creighton D; Yusuf K; Lapointe A; Yang J; Shah PS;
Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30518670
[TBL] [Abstract][Full Text] [Related]
59. Caffeine versus theophylline for apnea in preterm infants.
Henderson-Smart DJ; Steer PA
Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
[TBL] [Abstract][Full Text] [Related]
60. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Zhao Y; Tian X; Liu G
Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
